121 related articles for article (PubMed ID: 14707267)
1. Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4-amino-3-methylphenyl]-5-fluoro-benzothiazole: a potential surrogate marker for patient sensitivity.
Hose CD; Hollingshead M; Sausville EA; Monks A
Mol Cancer Ther; 2003 Dec; 2(12):1265-72. PubMed ID: 14707267
[TBL] [Abstract][Full Text] [Related]
2. Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells.
Brantley E; Trapani V; Alley MC; Hose CD; Bradshaw TD; Stevens MF; Sausville EA; Stinson SF
Drug Metab Dispos; 2004 Dec; 32(12):1392-401. PubMed ID: 15355884
[TBL] [Abstract][Full Text] [Related]
3. Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.
Chua MS; Kashiyama E; Bradshaw TD; Stinson SF; Brantley E; Sausville EA; Stevens MF
Cancer Res; 2000 Sep; 60(18):5196-203. PubMed ID: 11016648
[TBL] [Abstract][Full Text] [Related]
4. Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole.
Monks A; Harris E; Hose C; Connelly J; Sausville EA
Mol Pharmacol; 2003 Mar; 63(3):766-72. PubMed ID: 12606787
[TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to antitumor agent 2-(4-amino-3-methylphenyl) benzothiazole.
Loaiza-Pérez AI; Trapani V; Hose C; Singh SS; Trepel JB; Stevens MF; Bradshaw TD; Sausville EA
Mol Pharmacol; 2002 Jan; 61(1):13-9. PubMed ID: 11752201
[TBL] [Abstract][Full Text] [Related]
6. DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells.
Trapani V; Patel V; Leong CO; Ciolino HP; Yeh GC; Hose C; Trepel JB; Stevens MF; Sausville EA; Loaiza-Pérez AI
Br J Cancer; 2003 Feb; 88(4):599-605. PubMed ID: 12592376
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity.
Kang HJ; Kim HJ; Kwon SH; Kang BD; Eling TE; Lee SH; Bae I
Cancer Chemother Pharmacol; 2008 Sep; 62(4):689-97. PubMed ID: 18074135
[TBL] [Abstract][Full Text] [Related]
8. CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells.
Tan BS; Tiong KH; Muruhadas A; Randhawa N; Choo HL; Bradshaw TD; Stevens MF; Leong CO
Mol Cancer Ther; 2011 Oct; 10(10):1982-92. PubMed ID: 21831963
[TBL] [Abstract][Full Text] [Related]
9. 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole is a ligand and shows species-specific partial agonism of the aryl hydrocarbon receptor.
Bazzi R; Bradshaw TD; Rowlands JC; Stevens MF; Bell DR
Toxicol Appl Pharmacol; 2009 May; 237(1):102-10. PubMed ID: 19265716
[TBL] [Abstract][Full Text] [Related]
10. The experimental antitumor agents Phortress and doxorubicin are equiactive against human-derived breast carcinoma xenograft models.
Fichtner I; Monks A; Hose C; Stevens MF; Bradshaw TD
Breast Cancer Res Treat; 2004 Sep; 87(1):97-107. PubMed ID: 15377855
[TBL] [Abstract][Full Text] [Related]
11. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
[TBL] [Abstract][Full Text] [Related]
12. Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1.
Wang K; Guengerich FP
Chem Res Toxicol; 2012 Aug; 25(8):1740-51. PubMed ID: 22734839
[TBL] [Abstract][Full Text] [Related]
13. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.
Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Alley MC; Hose C; Ciolino HP; Yeh GC; Trepel JB; Vistica DT; Sausville EA
Mol Cancer Ther; 2004 Jun; 3(6):715-25. PubMed ID: 15210858
[TBL] [Abstract][Full Text] [Related]
14. The antitumour activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole in human gastric cancer models is mediated by AhR signalling.
Wang Y; Liu Y; Tang T; Luo Y; Stevens MFG; Cheng X; Yang Y; Shi D; Zhang J; Bradshaw TD
J Cell Mol Med; 2020 Jan; 24(2):1750-1759. PubMed ID: 31876059
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of acquired resistance to 2-(4-Amino-3-methylphenyl)benzothiazole in breast cancer cell lines.
Bradshaw TD; Stone EL; Trapani V; Leong CO; Matthews CS; te Poele R; Stevens MF
Breast Cancer Res Treat; 2008 Jul; 110(1):57-68. PubMed ID: 17674193
[TBL] [Abstract][Full Text] [Related]
16. Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles.
Hutchinson I; Chua MS; Browne HL; Trapani V; Bradshaw TD; Westwell AD; Stevens MF
J Med Chem; 2001 Apr; 44(9):1446-55. PubMed ID: 11311068
[TBL] [Abstract][Full Text] [Related]
17. Effects of zearalenone on mRNA expression and activity of cytochrome P450 1A1 and 1B1 in MCF-7 cells.
Yu Z; Hu D; Li Y
Ecotoxicol Environ Saf; 2004 Jun; 58(2):187-93. PubMed ID: 15157572
[TBL] [Abstract][Full Text] [Related]
18. Induction of CYP1A1 and CYP1B1 in T-47D human breast cancer cells by benzo[a]pyrene is diminished by arsenite.
Spink DC; Katz BH; Hussain MM; Spink BC; Wu SJ; Liu N; Pause R; Kaminsky LS
Drug Metab Dispos; 2002 Mar; 30(3):262-9. PubMed ID: 11854143
[TBL] [Abstract][Full Text] [Related]
19. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
Angus WG; Larsen MC; Jefcoate CR
Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
[TBL] [Abstract][Full Text] [Related]
20. Activation of the antitumor agent aminoflavone (NSC 686288) is mediated by induction of tumor cell cytochrome P450 1A1/1A2.
Kuffel MJ; Schroeder JC; Pobst LJ; Naylor S; Reid JM; Kaufmann SH; Ames MM
Mol Pharmacol; 2002 Jul; 62(1):143-53. PubMed ID: 12065765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
